Company / Shares Outstanding
Spyre Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
60.3M
FY2025
5-year range
2.6M / 60.3M
FY2021-FY2025
Trend
+67.1%
vs FY2024
Sector context
#145 of 212
Health Care
What the data says
At 60257023.00, Spyre Therapeutics, Inc.'s shares outstanding ranks #68 of 212 in the Health Care sector. Increased from 2614014.00 to 60257023.00 over the past 2 years.
Based on SEC 10-K filings.
60257023.00 in FY2025 with a 5-year CAGR of +15.7%.
Increased from 2614014.00 to 60257023.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +6.9%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
#68 of 212 in Health CareTop 32% of 212This company 60.3M Sector average 306.7M
▼
-80.4% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 67.1% year-over-year.
- Ranks #145 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 60.3M | +67.1% |
| FY2024 | 36.1M | +1279.4% |
| FY2023 | 2.6M | -94.7% |
| FY2022 | 49.4M | +2.9% |
| FY2021 | 48.0M | +64.9% |
| FY2020 | 29.1M | +20.5% |
| FY2019 | 24.1M | +44.8% |
| FY2018 | 16.7M | +10.2% |
| FY2017 | 15.1M | +54.5% |
| FY2016 | 9.8M | +1532.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026